| 常用名 | 普纳替尼-单盐酸盐 | CAS号 | 1114544-31-8 |
|---|---|---|---|
| 价格 | 纯度 | 99.0% | |
| 备货期 | 10天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: Ponatinib, also known as AP24534 is an oral drug for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL). It is a multi-targeted tyrosine-kinase inhibitor. Some forms of CML, those that have the T315I mutation, are resistant to current therapies such as imatinib. Ponatinib has been designed to be effective against these types of tumors. Ponatinib was approved in 2012. 物理化学性质: CAS号:1114544-31-8 常用中文名:普纳替尼-单盐酸盐 常用英文名:Ponatinib hydrochloride 分子式:C29H28ClF3N6O 分子量:569.02 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A 储存条件:2-8°C, 避光 |